PPARA and metabolic dysfunction-associated steatotic liver disease: In this study, we assumed that chronic treatment of γ-Oryzanol could attenuate HFD-induced NAFLD in rats by stimulating adipose tissue and liver FAs oxidation through regulating PPARα.